Commercialization of cell and gene therapies
The combination of sick patients, fragile products — and the potential for logistics issues and human error — can all add up to inefficiencies and higher costs.
Whether executing a clinical trial or scaling as part of commercialization, you need a coordinated, well controlled, end-to-end logistics solution to deliver personalized cellular immunotherapies.
How we deliver consistency and confidence
National delivery network
A national network combined with integrated and configurable technologies helps ensure the right product is safely delivered to the right place at the right time. This gives manufacturers the ability to rapidly scale.
White-glove service
Professional, uniformed drivers wearing ID badges hand deliver every dose to the person administering it. That way, the dose isn’t left unattended on a hospital loading dock. Each driver is carefully screened and extensively trained.
Actionable intelligence
Integrated technology is at the heart of this solution, grounded in configurable IT solutions that provide end-to-end visibility and real-time alerts.
Deep expertise
As an industry leader for autologous blood cell labeling, we provide doses for more than 20,000 patient studies annually.
Need more information? Please fill out the form below.
Thank you for connecting with us.